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Sphingolipids are ubiquitous membrane constituents
whose metabolites function as signaling molecules in
eukaryotic cells. Sphingosine 1-phosphate, a key sphin-
golipid second messenger, regulates proliferation, mo-
tility, invasiveness, and programmed cell death. These
effects of sphingosine 1-phosphate and similar phospho-
rylated sphingoid bases have been observed in organ-
isms as diverse as yeast and humans. Intracellular levels
of sphingosine 1-phosphate are tightly regulated by the
actions of sphingosine kinase, which is responsible for
its synthesis and sphingosine-1-phosphate phosphatase
and sphingosine phosphate lyase, the two enzymes re-
sponsible for its catabolism. In this study, we describe
the cloning of the Caenorhabditis elegans sphingosine
phosphate lyase gene along with its functional expres-
sion in Saccharomyces cerevisiae. Promoter analysis in-
dicates tissue-specific and developmental regulation of
sphingosine phosphate lyase gene expression. Inhibi-
tion of C. elegans sphingosine phosphate lyase expres-
sion by RNA interference causes accumulation of phos-
phorylated and unphosphorylated long-chain bases and
leads to poor feeding, delayed growth, reproductive ab-
normalities, and intestinal damage similar to the effects
seen with exposure to Bacillus thuringiensis toxin. Our
results show that sphingosine phosphate lyase is an es-
sential gene in C. elegans and suggest that the sphingo-
lipid degradative pathway plays a conserved role in reg-
ulating animal development.
Cell proliferation, migration, and apoptosis are critical to
embryogenesis. Elucidating the signal transduction pathways
that regulate these cellular processes can lead to insights into
normal animal development and the pathophysiology of devel-
opmental diseases. Sphingosine 1-phosphate (S1P)1 is an en-
dogenous sphingolipid metabolite that regulates mammalian
cell proliferation, apoptosis, and migration (1, 2). S1P is unique
in its ability to function in two signaling capacities, first as an
intracellular second messenger and second as a ligand for a
subset of G protein-coupled cell surface receptors of the endo-
thelial differentiation gene (Edg) family (3, 4). Additionally,
there is substantial evidence to support the existence of a
“sphingolipid rheostat” whereby cell fate decisions are deter-
mined by the ratio of intracellular levels of S1P, a known pro-
liferative stimulus, and ceramide, an inducer of apoptosis (5).
Intracellular levels of S1P are controlled by its synthesis,
catabolism, and export to the extracellular space. Sphingosine
kinase (SK) catalyzes the phosphorylation of sphingosine, gen-
erating S1P (6). SK activity increases in response to a variety of
inducers, including fetal calf serum, platelet-derived growth
factor, nerve growth factor, muscarinic acetylcholine agonists,
tumor necrosis factor , and cross-linking of the FcRI and
FcRI immunoglobulin receptors (7–13). Sphingosine phos-
phate lyase (SPL) catalyzes the cleavage of S1P at the C2–3
carbon bond to yield a long-chain aldehyde and ethanolamine
phosphate (14). SPL is a pyridoxal 5-phosphate-dependent
member of the carbon-carbon lyase subclass of aldehydelyases.
The reaction proceeds optimally at pH 7.4–7.6, requires chela-
tors due to sensitivity toward heavy metal ions, and is irrevers-
ible (15). SPL activity is ubiquitous in mammalian tissues, with
the notable exception of platelets, in which SPL activity is
absent. Although modulation of S1P levels is considered the
major biological function of this enzyme, the products of the
reaction can contribute to synthesis of both fatty acids and
phospholipids and have been shown to regulate sterol regula-
tory element binding protein processing in Drosophila melano-
gaster, indicating that the effects of this enzyme on lipid me-
tabolism and biology may be broader than previously
appreciated (16). SPL was first identified through a genetic
screen for sphingosine resistance in Saccharomyces cerevisiae
(17). Subsequently, functional SPL homologs of Mus musculus
and Homo sapiens were cloned and characterized (18, 19).
Furthermore, predicted protein sequences demonstrating sig-
nificant homology to known SPL proteins in D. melanogaster,
Neurospora crassa, Dictyostelium discoideum, Danio rerio, and
Arabidopsis thalliensis have been identified, indicating that
SPL may be highly conserved. In addition to its degradation by
SPL, S1P can be dephosphorylated back to sphingosine. En-
zymes capable of catalyzing the dephosphorylation of S1P com-
prise two groups, the S1P phosphatases, which demonstrate
sphingoid base substrate specificity, and a family of lipid phos-
phatases capable of dephosphorylating various substrates, in-
cluding lysophosphatidic acid, S1P, and phosphatidic acid
(20–22).
Knowledge of SPL, SK, and S1P phosphatase gene sequences
from a variety of genetically tractable organisms has made
possible the use of both forward and reverse genetic approaches
to elucidate the role of sphingolipid metabolism in animal
development. Recent studies have implicated roles for both S1P
and SPL in the developmental processes of different species,
including slime mold, zebrafish, and mouse (23–25).
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In this study, we have identified the gene encoding Caenorh-
abditis elegans SPL using nucleotide sequence homology and
complementation of a yeast SPL mutant. SPL promoter anal-
ysis using green fluorescent protein (GFP) reporter constructs
indicates tissue specific and developmental regulation of the
SPL gene. RNA interference (RNAi) was used to investigate the
importance of SPL in regulating metabolism of sphingolipid
signaling molecules and the role of SPL in vivo during devel-
opment and in the adult worm. Our results demonstrate that
C. elegans SPL expression is localized to intestinal cells and
that interference with SPL expression leads to accumulation of
phosphorylated and unphosphorylated long-chain bases. Fur-
thermore, inhibiting SPL expression results in severe intesti-
nal damage, egg laying defects, and semi-lethality. These stud-
ies demonstrate the importance of SPL in maintaining tight
regulation of bioactive sphingolipid metabolites and indicate
that SPL expression has a role in normal gut and reproductive
physiology, representing a first step toward understanding the
biological importance of the sphingolipid degradative pathway
in more complex animals, including humans.
EXPERIMENTAL PROCEDURES
Cloning of C. elegans SPL—Two open reading frames (gi1226312 
B0222.4; gi3801005  Y66H1B.4) with significant homology to the S.
cerevisae SPL gene were identified in the C. elegans genome by BLAST
search of the GenBankTM data base (17). Both these open reading
frames were reverse-transcribed and amplified by PCR from total
C. elegans RNA using the Access RT-PCR system (Promega) and the
DNA primer pairs 5-B0222.4 and 3-B0222.4, and 5-Y66H1B.4 and
3-Y66H1B.4 (Table I).
After restriction enzyme digestion, the resulting cDNA fragments
were cloned into EcoRI (B0222.4) and EcoRI and XhoI (Y66H1B.4) sites
of the pYES2 yeast shuttle vector (Invitrogen). The resulting galactose-
inducible constructs pYES2-B0222.4 and pYES2-Y66H1B.4 were eval-
uated for ability to functionally and biochemically complement relevant
S. cerevisiae mutant strains. For injected RNAi studies in C. elegans,
the B0222.4 and Y66H1B.4 sequences were cloned into pBluescript at
the EcoRI and EcoRI/XhoI sites, respectively. Additionally, cDNA of the
T07A9.1 gene, which is immediately upstream of Y66H1B.4 on chromo-
some IV, was amplified by RT-PCR using the DNA primer pair 5-
T07A9 and 3-T07A9, and the resulting DNA fragment was cloned into
pBluescript ( or ) at EcoRI and XhoI sites. RNA was produced from
the resulting plasmids pBS-B0222.4, pBS-Y66H1B.4, and pBS-
cT07A9.1 as described below.
Generation and Expression of C. elegans Reporter Gene Constructs—
For transcriptional reporter constructs, a promoter region of 512 nucle-
otides of Y66H1B.4 upstream untranslated sequence corresponding to a
position 3 to 515 relative to the ATG start codon was generated by
PCR from T07A9 cosmid template DNA using Vent DNA Polymerase
(New England BioLabs) and the primer pair PstIY66H1B and
SmaIY66H1B. Similarly, a promoter region of 3949 nucleotides of
T07A9.1 upstream untranslated sequence corresponding to a position
2 to 3951 relative to the ATG start codon was generated by PCR
from T07A9 cosmid template DNA using the primer pair PstIT07A9
and SmaIT07A9. Following restriction enzyme digestion, these PCR
products were cloned into PstI and SmaI sites of the GFP reporter
plasmids pPD95.75 and pPD95.67 (gifts of A. Fire and B. Meyer). The
resulting constructs, pY66H1B.4.75, pY66H1B.4.67, pT07A9.1.75,
and pT07A9.1.67, were used in transgenic experiments.
Creation of Transgenic Animals—Transformation of C. elegans dpy-
20(e1362) worms with reporter constructs was performed by microin-
jection of plasmid DNA into the distal arm of the hermaphrodite gonad
as described previously (26, 27). Reporter construct DNA was co-in-
jected with plasmid pMH86, allowing the recognition of transformants
by rescue of the Dpy phenotype (28). Two independently derived
stable lines for each construct were analyzed, PS4246 dpy-20(e1362);
syEx561[pMH86,pY66H1B.4.75] and PS4247 dpy-20(e1362);
syEx562[pMH86,pY66H1B.4.67]. GFP was visualized by mounting
live transgenic nematodes on 5% agarose 0.01% sodium azide and
viewed by fluorescence microscopy (Zeiss Axioskop) using a Chroma
High Q GFP long pass filter set (450-nm excitation and 505-nm
emission).
Yeast Strains and Growth Conditions—Strain JSK133, a derivative
of JK9–3d containing a dpl1::TRP1 allele, was transformed with pYES2
vector control, pYES2-DPL1, pYES2-B0222.4, and pYES2-Y66H1B.4
using the lithium acetate method (see Table II) (29). Transformants
were isolated by uracil prototrophy. Cells were grown in uracil media
containing 20 g/liter of either glucose or galactose. Sphingosine resist-
ance was analyzed using a dilutional assay, as previously reported (17).
Cells were also plated onto standard YEPD (yeast extract, peptone,
dextrose) media as a control. Sphingosine-enriched plates were made
with minimal media containing 0.0015% Nonidet P-40 and 50 M D-
erythro-sphingosine. At this concentration of Nonidet P-40, no effects on
cell viability are observed.
SPL Assay—Yeast strains of interest were grown to mid-logarithmic
phase (A600  1.0) in uracil media containing galactose as a carbon
source. Whole cell extracts were prepared as described previously (17),
adjusted for protein concentration, and evaluated for SPL activity as
described using as substrate [3H]dihydrosphingosine 1-phosphate, ob-
tained from American Radiolabeled Chemicals, Inc. (St. Louis, MO)
(30). Similarly, worms propagated on Escherichia coli HB101 strain
carrying either no vector or a Y66H1B.4 RNAi feeding construct were
harvested, washed in M9 and SPL extraction buffer, homogenized using
a Wheaton glass homogenizer, adjusted for protein concentration and
evaluated for SPL activity as above. Extracts containing only denatured
proteins were prepared by boiling for 5 min.
Worm Propagation and Collection of Staged Animals—Worms were
grown under standard conditions in nematode growth medium (31). To
synchronize C. elegans cultures worms were grown in liquid culture,
treated with alkaline hypochlorite treatment, resuspended in S basal
media, and harvested at various time points to obtain L4 larvae for
feeding experiments described below.
RNA Interference by Injection—The B0222.4, Y66H1B.4, and
T07A9.1 cDNAs were cloned into pBluescript in the multiple cloning
site. RNA complementary to each strand was synthesized using T3 and
T7 promoter regions and an in vitro transcription kit (Promega). The
two strands were annealed to make double-stranded RNA (dsRNA) and
injected into the distal gonads of 12 wild-type (N2 Bristol) young adult
C. elegans hermaphrodites as described (27). Uninjected hermaphro-
dites and hermaphrodites injected with a control dsRNA were handled
in parallel as controls. Eight hours after injection, each hermaphrodite
was transferred to a fresh culture plate, and 12-h cohorts of F1 progeny
were established. Progeny were examined daily with a dissecting mi-
croscope and by Nomarski microscopy (Zeiss Axioscop) until most ani-
mals reached adulthood and culture plates became too crowded with F2
progeny (32).
RNA Interference by Ingestion—Wild-type (N2 Bristol) L4 larvae
were plated on E. coli strain HB101 carrying an L440 plasmid contain-
ing the Y66H1B.4 insert (kind gift of Julie Ahringer, Cambridge, UK)
(33, 34). This plasmid expresses the corresponding target gene dsRNA
when induced with 1 mM isopropyl -D-1-thiogalactopyranoside (IPTG).
TABLE I
Primers used in these experiments
Primer name Primer sequence
5-B0222.4 5-GATCGAATTCACAGAATAAAATGGATTTTGCACTGGAGC-3
3-B0222.4 5-GACTGAATTCAGCACTTCACTCTG TTAAAGCATAAACAGCA-3
5-Y66H1B.4 5-GAGGAATTCATGGATTCGGTTAAGCACACAACCG-3
3-Y66H1B.4 5-AGCCTCGAGTTAATTAGAAGTT GAAGGTGGAGC-3
5-T07A9.1 5-GAGAATTCATGGAATCGATATCACGTTCG-3
3-T07A9.1 5-AGGGGCTCGAGTTAAAATGATTTTAAAAAATTG-3
PstIY66H1B.4 5-TTTACTGCAGCATTTCTACTCCAC-3
SmaIY66H1B.4 5-CGAATCCCGGGTAACCTGAAAA-3
PstIT07A9.1 5-TTAATCTGCAGAAAGCAATGGGAATCGTGAGAATC-3
SmaIT07A9.1 5-TCGTTCCCGGGTATTCGGACAATCAGGTGCTCCAGC-3
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L4 worms were fed and allowed to lay eggs, as described previously (35).
Progeny were harvested and evaluated by microscopy and biochemical
analysis, as described above.
Labeling of C. elegans Lipids—Worms were treated by RNAi by
ingestion as described above, except that worms were plated on IPTG
plates at the L1 stage and were harvested at L4 to adult stage. Worms
were then collected by scraping and resuspended in 1 ml of S basal
media containing 50 M [3H]serine (100 Ci/ml) and incubated for 4 h
at 20 °C. Following incubation the volume was brought up to 50 ml with
M9 buffer, and worms were pelleted by centrifugation at 3000 g for 10
min at 4 °C. Supernatant was discarded, and worms were washed two
times with 50 ml of M9 buffer each time. Washed worms were frozen in
liquid nitrogen and lyophilized until a flaky powder was obtained.
Lyophilized worms were stored at 80 °C until used.
Preparation and Analysis of C. elegans Lipid Extracts—A sample
containing 15 mg of lyophilized worms was placed in a glass tube, and
2 ml of ice-cold chloroform/methanol, 1:1 (v/v), was added to the tube.
The sample was homogenized by tip sonication (5  20 s) while on ice
and then centrifuged at 1500  g for 10 min. Supernatant was recov-
ered, and a second extraction was performed on the pellet. The two
supernatants were pooled and dried down in a Speed Vac. Lipid extract
was resuspended in 400 l of 1.5 M ammonium hydroxide by tip soni-
cation, and 2 ml of chloroform/methanol, 2:1 (v/v), was added while
vortexing. The sample was centrifuged at 1500  g for 10 min to obtain
a clear separation of the two phases. Both phases were recovered and
dried down in a Speed Vac. To compare the efficiency of the homogeni-
zation and extraction procedure between different samples, the total
amount of phosphatidylcholine present in the organic phase was deter-
mined following phospholipase B treatment (Waco Chemicals, Neuss,
Germany). Lipid equivalent to 250 g of phosphatidylcholine was re-
moved for TLC analysis. Lipid groups were separated by running TLC
(Silica Gel HL, 20 20 cm, Analtech, Newark, DE) and identified based
on known standards. Different solvent systems were applied. Phospho-
lipids were analyzed by applying 10–20% of the organic phase to a TLC
plate followed by a separation using the solvent system chloroform/
methanol/glacial acidic acid/0.9% sodium chloride, 20:10:3.2:1 (v/v, sol-
vent system A). The remainder of the organic phase was subjected to
mild alkaline hydrolysis by incubating for 1 h at 37 °C in 400 l of
methanol containing 0.1 M potassium hydroxide. Following hydrolysis
the lipids were dried down, resuspended in chloroform/methanol, 2:1
(v/v), and applied to a TLC plate. Lipids were separated using two-
dimensional TLC. Plates were developed in the first dimension using
the solvent system chloroform/methanol/4.2 M ammonium hydroxide,
9:7:2 (v/v, solvent system B) followed by a separation in the second
dimension using solvent system A. Spots corresponding to sphingoid
bases and ceramide were identified. Phosphorylated sphingoid bases
obtained in the water phase were analyzed using the same two-dimen-
sional TLC procedure. Aliquots were taken out throughout the homog-
enization and extraction procedures and evaluated for radioactivity by
scintillation counting. Spots corresponding to lipids of interest were
scraped from the TLC plates and counted for radioactivity.
RESULTS
Identification of C. elegans SPL—Based on a BLASTP search
of the GenBankTM data base against the DPL1 (dihydrosphin-
gosine phosphate lyase) gene sequence of S. cerevisiae, two
open reading frames were identified in the C. elegans genome.
Open reading frame B0222.4 on cosmid B0222 (representing a
portion of chromosome V) had been predicted to encode a glu-
tamate decarboxylase. Predicted coding sequence Y66H1B.4
was identified on yeast artificial chromosome Y66H1B (repre-
senting a portion of chromosome IV) and is noted to contain a
conserved pyridoxal phosphate-dependent decarboxylase do-
main. No experimental evidence for the function of either gene
was available. These two sequences are 39% identical and 60%
similar to one another. Y66H1B.4 is slightly more similar to the
SPL protein sequences of S. cerevisiae and Homo sapiens (40%
identical to DPL1 and 41% identical to human SPL) compared
with B0222.4 (36% identical to DPL1 and 38% identical to
human SPL). In each case, the region of similarity spans nearly
the entire length of each protein sequence. A predicted pyri-
doxal 5-phosphate binding lysine (shown in Fig. 1) is present
in both B0222.4 and Y66H1B.4. However, eliminating the con-
served region surrounding this lysine from the comparison did
not significantly affect the overall sequence similarity. To de-
termine whether B0222.4 and/or Y66H1B.4 encode a functional
SPL, cDNA from each transcript was created by reverse tran-
scription from total C. elegans RNA, amplified by PCR, and
cloned into the pYES2 yeast shuttle vector, in which genes are
induced in the presence of galactose. Both constructs were then
transformed into a haploid S. cerevisiae strain containing a null
dpl1 allele, the sole endogenous SPL gene of this organism.
This strain is extremely sensitive to the presence of D-erythro-
sphingosine in the media due to an inability to catabolize this
lipid. When active SPL proteins are expressed in this back-
ground, sphingosine sensitivity is abrogated. As shown in Fig.
2A, Y66H1B.4 expression in media containing galactose af-
forded substantial growth of the dpl1 strain on sphingosine,
whereas B0222.4 expression supported only marginal growth
(Fig. 2B). To determine whether B0222.4 and/or Y66H1B.4
were capable of restoring SPL activity to the dpl1 mutant,
whole cell extracts of dpl1 strains expressing either Y66H1B.4
or B0222.4 were prepared and evaluated for activity against a
radioactive dihydrosphingosine 1-phosphate substrate. Al-
though Y66H1B.4 expression restored SPL activity to the dpl1
strain, B0222.4 did not (Fig. 3). These findings indicate that
Y66H1B.4 encodes the C. elegans SPL, and we have renamed
this gene spl-1.
C. elegans SPL Is Expressed in a Tissue-specific Manner—
The organization of the spl-1 gene is shown in Fig. 4. The
coding region of spl-1 resides within a 3.2-kb sequence contain-
ing 10 exons and 9 introns on chromosome IV. The intragenic
region between spl-1 and its nearest 5 neighbor (hypothetical
gene T07A9.1) is 521 nucleotides. Due to the small size of this
region, Wormbase (available at www.wormbase.org) predicts
that spl-1 may be a downstream gene in an operon with
T07A9.1. Therefore, to evaluate gene expression from the spl-1
locus, GFP reporter constructs were created from both poten-
tial regulatory regions, which are located immediately 5 to
spl-1 and to the large intragenic region upstream of T07A9.1.
Reporter constructs with and without nuclear localization se-
quences were created to aid in interpretation of the fluorescent
signal. Reporter constructs and dpy-20 plasmid pMH86 were
simultaneously microinjected into the distal arm of the her-
maphrodite gonad of dpy-20(e1362) worms. Transformants
were identified by rescue of the Dpy phenotype (28). Lines in
which the F2 and subsequent generations demonstrated the
rescue phenotype were considered stable and were analyzed for
GFP expression. As shown in Fig. 5, GFP expression under
regulation of the spl-1 immediate upstream region was pro-
nounced and localized almost exclusively in the intestine. All
cells of the intestine expressed spl-1. In line PS4246, which
transmits the non-Dpy phenotype at 98%, most animals dem-
onstrated a fluorescent signal in the region just posterior to the
pharynx with no expression in the rest of the anterior gut.
Strong expression was also observed in the posterior gut of
most animals. No expression was detected in the gonad, body-
wall muscle, pharynx, vulva, or epidermis. Although a low
percentage of animals showed some expression in a pair of cells
in the head, expression was too weak and variable to identify
these cells. This expression pattern was consistent in worms
transformed with nuclear localizing reporter constructs and
TABLE II
Yeast strains used in these experiments
Name Relevant genotype
JSK133 a dp1::Trp
JS200 a dp11::Trp [pYES2-B0222.4 (URA3)]
JS201 a dp11::Trp [pYES2-Y66H1B.4 (URA3)]
JS203 a dp11::Trp [pYES2-DPL1 (URA3)]
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non-nuclear constructs. In contrast, only weak and non-tissue-
specific expression from the T07A9.1 promoter constructs was
observed (data not shown).
C. elegans SPL Expression Is Developmentally Regulated—
To determine whether spl-1 expression is developmentally reg-
ulated, GFP fluorescence was analyzed in transgenic animals
at all developmental stages. Although we were not able to
distinguish non-Dpy nematodes during embryogenesis, early to
comma stage embryos in line PS4246, which shows 98% trans-
mission of the transgene in larvae and adults, were devoid of
expression and expression in pretzel stage embryos was barely
detectable (Table III). In both transgenic lines analyzed, the
majority of L1 larvae and 100% of L2, L3, and L4 larvae and
adults showed medium to high expression, with the highest
levels of expression noted in older adults (Table III).
SPL Expression Is Required for Normal Development in
C. elegans—To assess whether the sphingolipid degradative
pathway serves a role in C. elegans development, spl-1 expres-
sion was inhibited using RNA interference. This method pro-
vides a potent and specific block to protein expression by in-
ducing degradation of the targeted endogenous mRNA. Toward
that end, full-length SPL dsRNA was created by in vitro tran-
scription and injected into adult hermaphrodite worms, as de-
scribed under “Experimental Procedures.” Animals injected
with full-length B0222.4 dsRNA and uninjected animals were
employed as negative controls. The resulting F1 progeny were
analyzed throughout development until they reached
adulthood.
Results representative of 12 separate injections of SPL
dsRNA are shown in Fig. 6. For SPL dsRNA-injected worms, all
eggs laid after 12 h post-injection demonstrated abnormali-
ties, although these ranged broadly in severity from worms
that did not develop beyond L1 or L2 stages to worms that
developed to adulthood and demonstrated defects of adult
structures. Compared with control F1s, animals inheriting
spl-1 dsRNA developed slowly, moved sluggishly, and were
thin, pale, and starved in appearance. The adults were smaller
than controls (Fig. 6A) and did not pump food actively. The
treated animals reached adulthood 24–48 h later than con-
trols. Adult hermaphrodites that inherited spl-1 dsRNA were
markedly different from controls especially in the gonad and
uterus. Although control animals had abundant nuclei in the
distal gonad and a row of developing oocytes in the proximal
gonad, affected hermaphrodites had poorly developed distal
gonads with fewer nuclei (Fig. 6B). Control adults had embryos
of progressive stages of development in the uterus, whereas the
number of developing oocytes in the proximal gonad of affected
hermaphrodites was significantly reduced. The embryos in the
uterus of affected progeny were also morphologically abnormal.
Those near the vulva were at late developmental stages, indi-
FIG. 1. Multiple sequence align-
ment. Sequences were aligned using the
ClustalW program (55). Conserved pyri-
doxal 5-phosphate binding lysine is
shown in boldface.
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cating a defect in egg laying. There was not a uniform progres-
sion of developmental stages in adjacent embryos suggesting a
defect in ovulation or cell division (Fig. 6, C–E). Embryonic and
larval semi-lethality was observed, and some premature death
of adults was also noted. None of these effects were found in
worms that inherited B0222.4 dsRNA, which were similar in
growth, appearance, and reproduction to uninjected worms.
Furthermore, no synergistic effects were observed when
B0222.4 and spl-1 dsRNA were injected together.
The Product of the spl-1 Gene Is the Predominant SPL of
C. elegans—It has been shown previously that RNAi can be
performed by feeding C. elegans bacteria containing plasmid
constructs that express dsRNA of interest (34). The advantages
of this method include its technical simplicity, the large num-
bers of affected progeny allowing biochemical analysis of
treated populations, and ability to manipulate the potency of
the effect by altering induction conditions, facilitating the iden-
tification of hypomorphic phenotypes. To confirm the develop-
mental phenotypes observed in RNAi by injection, to seek ad-
ditional phenotypes, and to determine the effect on SPL
activity, feeding RNAi was undertaken. Comparison of control
worms versus worms treated with spl-1 RNAi by ingestion
indicates that SPL enzyme activity is completely inhibited by
this procedure (Fig. 7). Therefore, the enzyme encoded by spl-1
is responsible for most, if not all, SPL activity in the worm.
Inhibition of C. elegans SPL Expression Leads to Intestinal
Cell Death and Egg Laying Defects—Using feeding RNAi, phe-
notypes similar to those observed in injection RNAi were ap-
preciated, including pallor, shrunken gonads, bloated appear-
ance, and unlaid eggs (Fig. 8). Rare adult hermaphrodite
worms were identified with hatched larvae within them (the
“bag of worms” phenotype). Pallor was a consistent finding,
present in all progeny of treated animals. Furthermore, the
intestines of many worms appeared strikingly abnormal,
shrunken and vacuolated. The onset of these defects was late.
Worms appeared normal throughout the larval stages, whereas
pallor became evident as worms reached early adulthood, and
more pronounced phenotypes were appreciated only in adults
more than 24 h old. These phenotypes persisted in adult worms
transferred to non-transformed bacterial plates, indicating
that the defects caused by SPL inhibition are irreversible.
Whereas egg laying was unaffected in worms fed RNAi as
adults, it was modestly diminished in worms subjected to RNAi
throughout development (data not shown).
The Observed Developmental Defects Are Specific to spl-1—
Although the reporter studies described above indicate that spl-1
is transcribed independently of T07A9.1 and is unlikely to be in
an operon regulated by the T07A9.1 promoter, it was important
to verify that the phenotypes observed in spl-1 RNAi-treated
worms were caused by inhibition of spl-1 expression rather than
a polar effect leading to a block in expression of the hypothetical
T07A9.1 protein product. To maximize the potency of the block in
expression, injected RNAi was employed to inhibit expression of
T07A9.1. Importantly, inhibition of T07A9.1 expression resulted
in no demonstrable effects on egg laying, gonadal development,
or growth of the injected worms (data not shown). Therefore, it
appears that specific inhibition of spl-1 expression produces the
aforementioned abnormalities in the growth, developmental pro-
gression, and reproduction of C. elegans.
Inhibition of C. elegans SPL Expression Leads to Accumula-
tion of Phosphorylated and Unphosphorylated Long-chain
Bases—To gain insight into potential mechanisms responsible
for the developmental defects observed in SPL-deficient worms,
the effect of spl-1 RNAi on serine incorporation into worm
sphingolipids and phospholipids was examined, as described
under “Experimental Procedures.” As shown in Table IV, spl-1
RNAi treatment was associated with a 1.7-fold increase in the
amount of serine incorporated into phosphorylated long-chain
bases and a 2.7-fold increase in unphosphorylated long-chain
bases in comparison to control worms. In contrast, serine in-
corporation into ceramide, phosphatidylserine, phosphati-
dylethanolamine, and phosphatidylcholine was not appreciably
altered in the RNAi worms. Thus, specific accumulation of
phosphorylated and unphosphorylated long-chain bases results
FIG. 3. SPL activity of Y66H1B.4 expressed in yeast. Whole cell
extracts of yeast strains were evaluated for SPL activity. Relative and
absolute SPL activities are shown for Y66H1B.4. For dpl1 versus dpl1
(Y66H1B.4), p  0.003. This is representative of two separate
experiments.
FIG. 2. Complementation of a yeast SPL mutant. A, functional
complementation by Y66H1B.4 of yeast strain JSK133, which contains
a null allele of the endogenous yeast SPL, DPL1. Saturated cultures of
JSK133 transformed with pYES2 vector (dpl1  vector) or with pYES2-
Y66H1B.4 (dpl1 Y66H1B.4) were adjusted for A600  5 and serially
diluted as indicated. Cells were template-inoculated onto YEPD plates
or plates containing sphingosine and galactose as a carbon source, as
described under “Experimental Procedures.” B, same as above, except
that strains include wild type, JSK133 plus vector, JSK133 plus
pYES2-B0222.4 (dpl1  B0222.4), and JSK133 plus pYES2-DPL1
(dpl1  DPL1). This is representative of three separate experiments.
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from RNAi treatment and may contribute to the reproductive
and anatomical defects observed in spl-1-deficient worms.
DISCUSSION
In this study, we have identified the C. elegans SPL gene as
“spl-1” using nucleotide sequence homology searches and func-
tional complementation in yeast. This gene appears to encode
the sole or predominant SPL in C. elegans, because inhibition of
its expression is associated with undetectable levels of SPL
activity in vivo.
C. elegans spl-1 expression is regulated in a tissue-specific
manner, with robust expression detected in intestinal cells and
faint expression in the head. Our data are in agreement with a
more extensive C. elegans developmental analysis presented by
the Nematode Expression Pattern Data base (36). This highly
restricted tissue specificity is unlike that found in Homo sapi-
ens and Mus musculus, where SPL is expressed in most tissues.
Little is known about the physiology of C. elegans intestinal
cells, although they have been shown to store nutrients and
secrete digestive enzymes into the gut lumen and are likely to
carry out detoxification, storage, and metabolic functions (37).
Although in its natural environment C. elegans might ingest
plant particles containing sphingolipids, laboratory strains are
raised solely on E. coli, which does not synthesize or contain
sphingolipids. Intermediates that accumulate in the absence of
SPL activity may, thus, be derived from endogenous pathways
or potentially from trace sphingolipids present in the culture
media. It is possible that the localization of spl-1 points toward
FIG. 5. C. elegans SPL expression using GFP reporter trans-
genes. Two adult hermaphrodites of strain PS4246 showing GFP ex-
pression throughout the intestine (arrows) are shown. Scale bar repre-
sents 1 mm. Nomarski and fluorescent images were merged using
PhotoShop. Ant., anterior.
FIG. 6. Worms treated with spl-1 RNAi by injection. Nomarski
images of adult hermaphrodites of both untreated (left panels) and
treated (right panels) nematodes are shown. In all panels, dorsal ori-
entation is upward. A, images of the entire hermaphrodite showing the
difference in body size between treated and untreated individuals.
Anterior is to the left. Scale bar, 1 mm. B, section of the proximal (lower
arrows) and distal (upper arrows) gonad arms showing reduced size and
structural abnormalities in the treated hermaphrodite. C–E, the uterus
in the region of the vulva (arrowheads) showing a progression of em-
bryonic cell division from right to left in the untreated animals and the
presence of both advanced (multicellular) and delayed/abnormal em-
bryos (one-two nuclei) in the treated hermaphrodites. The vulva in the
normal hermaphrodite in panel C is just to the left of the field of view.
The scale bar in panel B represents 0.1 mm and applies to B–E.
TABLE III
GFP reporter expression during development
Developmental stage Number scored % Expressing GFP
%
Pre-comma stage embryos 24 0
Comma stage embryos 9 0
Pretzel stage embryos 22 23
L1 larvae 22 73
L2 larvae 20 100
L3 larvae 20 100
L4 larvae 21 100
Adults 25 100
FIG. 4. Organization of the C. el-
egans SPL gene. Shown are Y66H1B.4
and its gene organization, T07A9.1, and
the two potential 5 regulatory regions for
Y66H1B.4 (T07A9.1-Y66H1B.4 intragenic
region and QRS-6-T07A9.1 intragenic re-
gion). RPS24 is encoded by the opposite
DNA strand, as indicated by the arrows.
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a critical function in gut development and/or maintenance of
intestinal integrity. Interestingly, we have observed a similar
intestine-specific expression pattern in the SPL of D. melano-
gaster, indicating that this may be a widespread phenomenon
in invertebrate organisms (38). Furthermore, the finding of
spl-1 expression in the head indicates a potential role in neu-
rodevelopment, which is consistent with evidence suggesting a
role for lysophospholipid signaling in nervous system develop-
ment and function in mammals (39).
The onset of spl-1 expression occurs at the time of egg hatch-
ing, and expression remains high throughout the life of the
organism. The results of our GFP reporter assays indicate that
the small intragenic region immediately upstream of
Y66H1B.4 is the true spl-1 promoter. It appears that this
500-bp region is sufficient to provide both spatial and tempo-
ral regulation of spl-1 gene expression. Systematic study of this
promoter using reporter gene constructs, mutational analysis,
and deletional analysis should allow identification of the spe-
cific sequences involved in the regulation of spl-1 expression.
Analysis of sphingolipid metabolites throughout development,
in combination with the use of transgenic approaches resulting
in ectopic and/or constitutive spl-1 expression, should elucidate
the functional significance of this pattern of gene expression.
Importantly, C. elegans spl-1 expression is critical for the
maintenance of intestinal integrity and normal reproduction.
Without spl-1 expression, animals become bloated, pale, con-
gested with eggs and hatched larvae, and demonstrate
shrunken gut and gonadal structures. The finding of a pheno-
type involving intestinal cell integrity in SPL-inhibited ani-
mals is consistent with its observed expression pattern,
whereas effects on the gonad are less directly explained. It
could be postulated that the gonadal and egg laying defects
observed in the spl-1 RNAi-treated worms is due to a nonspe-
cific effect of starvation. However, this is not likely, because
this type of reproductive defect has not been described in other
mutants in which starvation is a prominent feature (40). Fur-
thermore, diminished egg laying was observed only in worms
treated with spl-1 RNAi throughout development, suggesting
that this defect has a developmental basis. Interestingly, the
intestine appears to play a critical role in the nurture of germ
cells by producing yolk proteins that are imported into the
developing oocytes and serving as nurse cells for the primordial
germ cells (37). Therefore, potential toxicity to intestinal cells
induced by S1P accumulation or other metabolic disturbances
associated with spl-1 inhibition may affect egg maturation by
blocking this supportive role of intestinal cells in reproduction.
S1P may have direct effects on reproduction, provided it can
move from intestinal cells to other tissues through normal
diffusion, secretion, or facilitated transport. This concept is
supported by the observation that S1P concentration gradients
regulate mammalian endothelial and smooth muscle cell mi-
gration through receptor signaling mechanisms (41, 42). Alter-
natively, once intestinal cell membranes are disrupted and the
integrity of the intestinal tract has been violated, S1P and/or
other metabolites and digestive enzymes may escape, causing
pleiotropic effects on nearby organs.
Interestingly, the vacuolization, pallor, shrinkage, and ulti-
mate destruction of the intestines, as well as the gonadal de-
fects observed in worms treated with spl-1 RNAi are remark-
ably similar to that observed in worms treated with Cry
proteins of the Bacillus thuringiensis (Bt) bacterium. These
potent natural insecticides have been utilized to create trans-
genic food plants resistant to a wide variety of insect pests (43,
44). Although their precise mode of action is not known, these
toxins induce cell damage by intercalating into the cell mem-
branes of insect midgut epithelial cells, causing pore formation
(45, 46). C. elegans also develops intestinal damage in response
to some Cry proteins (47, 48). How might Bt toxin and spl-1
inhibition induce the same effect on nematode intestinal cells?
S1P accumulation may result in a direct or indirect disruption
of the membrane integrity of the intestinal cell. Lysophospho-
FIG. 7. SPL activity after RNAi by ingestion. Worms were treated
with RNAi constructs as described in Fig. 8. Control animals were
grown on plates containing IPTG and OP50 (no RNAi construct). At
48 h, worms were harvested, washed to remove bacteria, and homoge-
nized using a Wheaton glass homogenizer followed by vortexing in the
presence of glass beads. Extracts were normalized for protein content
and assayed for SPL activity as described under “Experimental Proce-
dures.” For RNAi-treated versus untreated worms, p  0.001. Residual
SPL activity in RNAi-treated worms is apparent when compared with a
denatured extract from wild type worms (Denatured Wild Type).
FIG. 8. Worms treated with spl-1 RNAi by ingestion. Wild type
N2 Bristol hermaphrodite worms were grown on plates containing
bacteria expressing an spl-1 RNAi construct. After 48 h, animals were
evaluated in comparison to worms grown on plates containing IPTG
and OP50, which does not contain an RNAi vector. Images are obtained
using Nomarski optics, as described under “Experimental Procedures.”
This is representative of three separate experiments. In all panels,
adult hermaphrodites are shown. Anterior is to the right; dorsal is
upward. The scale bar shown in A represents 0.1 mm and applies to
A–F. A, intestine (black arrow) is shrunken and appears constricted just
posterior to the pharyngeal bulb. B, anterior portion of the intestine
(black arrow) is shrunken and constricted. C, posterior portion of the
intestine (black arrow) contains vacuoles (arrowheads). D, both proxi-
mal (left white arrow) and distal (right white arrow) regions of the
gonad are shrunken. E, contents of the uterus include abnormally late
stage embryos (short white arrows). F, a bag of worms evidenced by the
presence of hatched embryos within the mother. Arrowheads indicate
small larval pharyngeal bulbs.
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lipids are known to exert various membrane modulating influ-
ences, including detergent effects that result in destabilization
and disruption of membranes and chaperone-like effects, which
facilitate protein folding (49–51). Either direct membrane dis-
ruption or interference with ion channels or other proteins
required to maintain membrane stability and integrity could
ultimately result in cell lysis. Other plausible mechanisms
include inhibition of SPL-1 protein by Bt toxin, binding of Bt
toxin to SPL-1 in membranes, or influences on downstream
signaling events common to both the Bt toxin pathway and S1P
pathways.
Finally, spl-1 RNAi treatment led to significant accumula-
tion of both phosphorylated and unphosphorylated long-chain
bases, as would be expected from a block in SPL activity (Fig.
9). (In contrast, inhibiting expression of a putative C. elegans
SK led to a substantial increase in long-chain bases but no
increase in phosphorylated long-chain bases.)2 The observed
lipid changes are specific, in that phospholipid and ceramide
levels are not significantly perturbed by loss of spl-1 expres-
sion. Increases in long-chain bases of this magnitude are con-
sistent with levels observed in mutant models lacking spl-1
expression in other organisms, as well as in mammalian cells in
which the SPL gene is disrupted and in mammalian cells
overexpressing recombinant SK (38, 52–54). In each of the
above cases, this degree of phosphorylated long-chain base
accumulation was sufficient to induce signals and result in
downstream biological effects. Thus, the perturbation of phos-
phorylated long-chain bases observed in our experiments could
potentially exert significant physiological effects in the devel-
oping and adult worm.
In summary, our results demonstrate that spl-1 is an essen-
tial gene in C. elegans and that inhibiting spl-1 expression
results in accumulation of bioactive sphingolipid metabolites
and associated severe developmental and reproductive pheno-
types and indicate that the sphingolipid degradative pathway
plays a conserved role in the regulation of animal development.
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